NCT05486780

Brief Summary

The research will be carried out in the Cardio Vascular Surgery (CVS) Intensive Care Unit (ICU) of Ankara Training and Research Hospital (TRH) . Patients will be divided into two Experimental (n=24) and control (n=24) groups. Simple randomization method will be used in the study, provided that there are equal numbers of male and female patients in the experimental and control groups, regardless of the age of the patients. Patients in the experimental group will use a digital window. The "Patient Information Form","Richard-Campbell Sleep Questionnaire\_RCSQ " and " Day and Night Perception Form" will be used in the data collection phase. Ethics committee approval was received from Ankara Yıldırım Beyazıt University Ethics Committee in order to conduct the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 4, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

August 8, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2023

Completed
Last Updated

August 4, 2022

Status Verified

August 1, 2022

Enrollment Period

4 months

First QC Date

August 2, 2022

Last Update Submit

August 2, 2022

Conditions

Keywords

intensive care unitsdaylightpostoperative patientsleep qualityclinical trial

Outcome Measures

Primary Outcomes (2)

  • 1.Change in sleep quality

    Sleep quality will be measured based on the patient report by Richard-Campbell Sleep Questionnaire. A higher score means an increase in sleep quality.

    Baseline measurements (Pre-op), at the post-op 1., 2. and 3. days after the completion of the interventions

  • 2. Change in day and night perception status

    Day and night perception status will be measured based on the patient report byDay and Night Perception Form.

    Measurements at the post-op 1., 2. and 3. days after the completion of the interventions

Study Arms (2)

Digital window

EXPERIMENTAL

The patients who will be assigned to the experimental group will sleep on the 1st, 2nd, and 3rd beds. Experimental group patients are in the field of view of the digital window. A digital window is a tool designed by the researcher to enable patients to differentiate between day and night.

Behavioral: Digital Window

Control group

NO INTERVENTION

the patients who will be assigned to the control group will sleep in the 4th, 5th, and 6th beds. Control group patients are not in the field of view of the digital window. Data collection will be completed by the researcher by completing the Day and Night Perception Form and the Richards Campbell Sleep Scale (Post-Test) on the 1st, 2nd, and 3rd days of post-op for the patients in the control group who are not in the field of view of the digital window.

Interventions

Digital WindowBEHAVIORAL

For the digital window, a regal brand, 43R654FC, 43-inch (109 cm) television was used. A three-dimensional frame was built to give the appearance of a window around the television. For the digital window, a regal brand, 43R654FC, 43-inch (109 cm) television was used. A three-dimensional frame was built to give the appearance of a window around the television. Data collection will be completed by the researcher completing the Day and Night Perception Form and the Richards Campbell Sleep Scale (Post-Test) on the 1st, 2nd, and 3rd days of post-op for the patients in the experimental group who are in the field of view of the digital window.

Digital window

Eligibility Criteria

Age19 Years - 79 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsResearch shows that gender affects sleep quality in patients with heart valve and coronary artery disease. Therefore, we will randomize participants into the groups, which were similar in terms of gender.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient has CABG and heart valve surgery
  • The patient's willingness to participate in the study voluntarily
  • Patient's ability to answer research questions
  • The patient's age range is 19-79
  • Being in the post-op period and staying in the ICU for at least 48 hours after the post-op period
  • Determined as a Glasgow Coma Scale (GCS) score of 9 or higher

You may not qualify if:

  • Patient undergoing another operation other than CABG and heart valve surgery
  • The patient is intubated
  • The patient's use of sedating drugs
  • The patient is in delirium
  • Patient's age other than 19-79
  • Staying in the ICU for less than 48 hours after the post-op period
  • Determined as GKS score below 9

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Training and Research Hospital-Cardiovascular Surgery Intensive Care Unit

Ankara, Altındag, 06230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronary Artery DiseaseHeart Valve DiseasesSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • İlkbal Bezek, Master Student

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

İlkbal Bezek, Master Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master Student

Study Record Dates

First Submitted

August 2, 2022

First Posted

August 4, 2022

Study Start

August 8, 2022

Primary Completion

December 15, 2022

Study Completion

January 10, 2023

Last Updated

August 4, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

The confidentiality of the data used in the study will be protected.

Locations